DRAVP ID |
Name |
Sequence |
Target Organism |
Pubmed/Patent ID |
DRAVPe01608 |
MU89 (Octa 1 dp) |
RRWYRWWRRRWYRWWR |
HSV |
17681018 |
DRAVPe01609 |
Hepta 1 |
RWWRWWR |
HSV |
17681018 |
DRAVPe01610 |
MU92 (Hepta 1 dp) |
RWWRWWRRWWRWWR |
HSV |
17681018 |
DRAVPe01611 |
Deca 1 |
YRWWRWARRW |
HSV |
17681018 |
DRAVPe01612 |
MU94 (Deca 1 dp) |
YRWWRWARRWYRWWRWARRW |
HSV |
17681018 |
DRAVPe01613 |
N-[RLLR]3 |
APKAMRLLRRLLRRLLR |
HSV |
17681018 |
DRAVPe01614 |
RLLR5 |
RLLRRLLRRLLRRLLRRLLR |
HSV |
17681018 |
DRAVPe01615 |
MU103 |
RRRRRRRWWWRRRRRRRR |
HSV |
17681018 |
DRAVPe01616 |
MU104 |
RRRRRRRRRRRRRRRWWW |
HSV |
17681018 |
DRAVPe01617 |
ApoEdpL-W |
WRKWRKRWWWRKWRKRWW |
HSV,HIV,VSV |
17681018 |
DRAVPe01640 |
Alloferon-1 [H1K] |
KGVSGHGQHGVHG |
HHV,CBV2 |
21766388 |
DRAVPe01641 |
Alloferon-1 [H1R] |
RGVSGHGQHGVHG |
HHV,CBV2 |
21766388 |
DRAVPe01642 |
Alloferon-1 [H1A] |
AGVSGHGQHGVHG |
HHV,CBV2 |
21766388 |
DRAVPe01653 |
Peptide 2 |
GGVLVQPG |
SARS-CoV-2,HCMV,VZV |
34502335 |
DRAVPe01654 |
Peptide 3 |
GGVLVQPG |
SARS-CoV-2,HCMV,VZV |
34502335 |
DRAVPe01655 |
Peptide 4 |
GGVLVQPG |
SARS-CoV-2,HCMV,VZV |
34502335 |
DRAVPe01656 |
Peptide 5 |
GVLVQ |
SARS-CoV-2,HCMV,VZV |
34502335 |
DRAVPe01657 |
Peptide 6 |
GVLV |
SARS-CoV-2,HCMV,VZV |
34502335 |
DRAVPe01814 |
Hp1036 |
ILGKIWEGIKSIF |
HSV-1 |
24315793 |
DRAVPe01815 |
Hp1239 |
ILSYLWNGIKSIF |
HSV-1 |
24315793 |
DRAVPe01816 |
Eval418 |
LWGEIWNTVKGLI |
HSV-1 |
29290802 |
DRAVPe01817 |
Eval418-FH2 |
LWGHIWNFVHGLI |
HSV-1 |
29290802 |
DRAVPe01818 |
Eval418-FH3 |
LWHHIWNFVHGLI |
HSV-1 |
29290802 |
DRAVPe01819 |
Eval418-FH4 |
LWHHIWNTVHHLI |
HSV-1 |
29290802 |
DRAVPe01820 |
Eval418-FH5 |
LWHHIWHTVHHLI |
HSV-1 |
29290802 |
DRAVPe01829 |
KP |
AKVTMTCSAS |
HSV-1 |
30654366 |
DRAVPe01830 |
K10S |
KKVTMTCSAS |
HSV-1, CoxV B5, AdV, VSV |
30654366 |
DRAVPe01836 |
L12P |
LCLRNWDQGHRP |
HSV-1, CoxV B5 |
30654366 |
DRAVPe01878 |
Pep19-2.5 |
GCKKYRRFRWKFKGKFWFWG |
HIV, HSV-1, HCV, HBV |
22457281 |
DRAVPe01879 |
Pep19-4 |
GKKYRRFRWKFKFGKWFWFG |
HIV, HSV-1, HCV |
22457281 |